annual EBITDA:
-$215.24M-$9.56M(-4.65%)Summary
- As of today (June 12, 2025), DAWN annual EBITDA is -$215.24 million, with the most recent change of -$9.56 million (-4.65%) on December 31, 2024.
- During the last 3 years, DAWN annual EBITDA has fallen by -$142.70 million (-196.70%).
- DAWN annual EBITDA is now -1479.52% below its all-time high of -$13.63 million, reached on December 31, 2020.
Performance
DAWN EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$40.17M+$24.40M(+37.79%)Summary
- As of today (June 12, 2025), DAWN quarterly EBITDA is -$40.17 million, with the most recent change of +$24.40 million (+37.79%) on March 31, 2025.
- Over the past year, DAWN quarterly EBITDA has increased by +$26.48 million (+39.73%).
- DAWN quarterly EBITDA is now -146.24% below its all-time high of $86.88 million, reached on March 1, 2019.
Performance
DAWN quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$188.76M+$26.48M(+12.30%)Summary
- As of today (June 12, 2025), DAWN TTM EBITDA is -$188.76 million, with the most recent change of +$26.48 million (+12.30%) on March 31, 2025.
- Over the past year, DAWN TTM EBITDA has increased by +$37.80 million (+16.69%).
- DAWN TTM EBITDA is now -205.04% below its all-time high of $179.70 million, reached on September 1, 2019.
Performance
DAWN TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
DAWN EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.7% | +39.7% | +16.7% |
| 3 y3 years | -196.7% | -45.1% | -124.3% |
| 5 y5 years | -1343.9% | -1934.1% | -308.0% |
DAWN EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -196.7% | at low | -232.2% | +64.9% | -124.3% | +35.3% |
| 5 y | 5-year | -1479.5% | at low | -232.2% | +64.9% | -308.0% | +35.3% |
| alltime | all time | -1479.5% | at low | -146.2% | +64.9% | -205.0% | +35.3% |
DAWN EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$40.17M(-37.8%) | -$188.76M(-12.3%) |
| Dec 2024 | -$215.24M(+4.6%) | -$64.57M(-312.5%) | -$215.24M(+2.5%) |
| Sep 2024 | - | $30.38M(-126.6%) | -$210.08M(-28.0%) |
| Jun 2024 | - | -$114.40M(+71.6%) | -$291.80M(+28.8%) |
| Mar 2024 | - | -$66.65M(+12.2%) | -$226.57M(+10.2%) |
| Dec 2023 | -$205.68M(+40.5%) | -$59.41M(+15.7%) | -$205.68M(+8.9%) |
| Sep 2023 | - | -$51.34M(+4.4%) | -$188.83M(+6.7%) |
| Jun 2023 | - | -$49.16M(+7.4%) | -$177.03M(+7.6%) |
| Mar 2023 | - | -$45.77M(+7.5%) | -$164.45M(+12.3%) |
| Dec 2022 | -$146.38M(+101.8%) | -$42.56M(+7.7%) | -$146.38M(+16.4%) |
| Sep 2022 | - | -$39.53M(+8.1%) | -$125.71M(+19.3%) |
| Jun 2022 | - | -$36.59M(+32.1%) | -$105.36M(+25.2%) |
| Mar 2022 | - | -$27.70M(+26.5%) | -$84.16M(+16.1%) |
| Dec 2021 | -$72.54M | -$21.89M(+14.1%) | -$72.51M(+29.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$19.18M(+24.7%) | -$56.12M(+37.8%) |
| Jun 2021 | - | -$15.39M(-4.0%) | -$40.73M(+47.1%) |
| Mar 2021 | - | -$16.04M(+190.9%) | -$27.69M(+103.2%) |
| Dec 2020 | -$13.63M(-8.6%) | -$5.51M(+45.6%) | -$13.63M(-185.2%) |
| Sep 2020 | - | -$3.79M(+60.9%) | $16.00M(-81.4%) |
| Jun 2020 | - | -$2.35M(+19.1%) | $86.09M(-5.1%) |
| Mar 2020 | - | -$1.98M(-108.2%) | $90.75M(-49.5%) |
| Dec 2019 | -$14.91M | - | - |
| Dec 2019 | - | $24.11M(-63.6%) | $179.60M(-0.1%) |
| Sep 2019 | - | $66.31M(+2780.5%) | $179.70M(+10.2%) |
| Jun 2019 | - | $2.30M(-97.4%) | $163.08M(-6.0%) |
| Mar 2019 | - | $86.88M(+258.8%) | $173.47M(+100.3%) |
| Dec 2018 | - | $24.22M(-51.3%) | $86.60M(+38.8%) |
| Sep 2018 | - | $49.69M(+291.3%) | $62.38M(+391.3%) |
| Jun 2018 | - | $12.70M | $12.70M |
FAQ
- What is Day One Biopharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals annual EBITDA year-on-year change?
- What is Day One Biopharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals quarterly EBITDA year-on-year change?
- What is Day One Biopharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Day One Biopharmaceuticals?
- What is Day One Biopharmaceuticals TTM EBITDA year-on-year change?
What is Day One Biopharmaceuticals annual EBITDA?
The current annual EBITDA of DAWN is -$215.24M
What is the all time high annual EBITDA for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high annual EBITDA is -$13.63M
What is Day One Biopharmaceuticals annual EBITDA year-on-year change?
Over the past year, DAWN annual EBITDA has changed by -$9.56M (-4.65%)
What is Day One Biopharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of DAWN is -$40.17M
What is the all time high quarterly EBITDA for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high quarterly EBITDA is $86.88M
What is Day One Biopharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, DAWN quarterly EBITDA has changed by +$26.48M (+39.73%)
What is Day One Biopharmaceuticals TTM EBITDA?
The current TTM EBITDA of DAWN is -$188.76M
What is the all time high TTM EBITDA for Day One Biopharmaceuticals?
Day One Biopharmaceuticals all-time high TTM EBITDA is $179.70M
What is Day One Biopharmaceuticals TTM EBITDA year-on-year change?
Over the past year, DAWN TTM EBITDA has changed by +$37.80M (+16.69%)